RAB8B and atrial fibrillation: Based on the previously reported GWAS (https://www.ebi.ac.uk/gwas/) and the UK Biobank GWAS catalog (https://www.nealelab.is/uk-biobank), RAB8B affects AF, systolic blood pressure (SBP), heart rate (HR), and body mass index (BMI), while FBXL22 affects AF, HR, and BMI.